Clover Health Investments Corp. - Class A (CLOV) closed at $3.73 on November 20, 2026, down 1.1% from the previous close, on volume of 6,227,159 shares (30-day average 4,622,485).
Data as of November 20, 2026.
| # | Date | Strategy | Legs | Contracts | Position |
|---|---|---|---|---|---|
| 1 | Nov 4, 2026 | Put Spread | 13-Nov-264 : 4.5 P | 11,220 | |
| 2-3 | The next 2 largest trades are for Premium members. Start a 7-day free trial | ||||
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 19, 2026. See the largest for 5, 30, 60 and 90 days
TipRanks (Fri, 20-Nov 2:21 PM ET)
Health insurers extend slide amid ‘Medicare for All’ push
Seeking Alpha News (Thu, 19-Nov 12:36 PM ET)
Biggest stock movers Tuesday: Managed care stocks, ACM, RCAT, and more
Seeking Alpha News (Tue, 17-Nov 9:51 AM ET)
Managed care drops as U.S. seeks crackdown on Medicare, Medicaid fraud
Seeking Alpha News (Tue, 17-Nov 8:32 AM ET)
Clover Health Releases Supplemental Shareholder Q&A Responses
TipRanks (Mon, 16-Nov 7:17 PM ET)
Clover Health Reports Third Quarter 2026 Results
Globe Newswire (Wed, 4-Nov 4:05 PM ET)
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
Globe Newswire (Mon, 26-Oct 4:05 PM ET)
Globe Newswire (Mon, 19-Oct 4:30 PM ET)
Market Chameleon (Fri, 9-Oct 7:48 AM ET)
Clover Health’s wide-network PPO earns a 5-Star CMS rating for 2027, unlocking year-round enrollment
Market Chameleon (Fri, 9-Oct 3:06 AM ET)
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
Clover Health Investments Corp. - Class A trades on the NASDAQ stock market under the symbol CLOV.
As of November 20, 2026, CLOV stock price declined to $3.73 with 6,227,159 million shares trading.
CLOV has a beta of 1.91, meaning it tends to be more sensitive to market movements. CLOV has a correlation of 0.16 to the broad based SPY ETF.
CLOV has a market cap of $1.98 billion. This is considered a Small Cap stock.
Last quarter Clover Health Investments Corp. - Class A reported $759 million in Revenue and $.01 earnings per share. This beat revenue expectation by $19 million and met earnings estimates .
In the last 3 years, CLOV traded as high as $5.59 and as low as $.61.
The top ETF exchange traded funds that CLOV belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
CLOV has outperformed the market in the last year with a return of +60.8%, while the SPY ETF gained +5.2%. However, in the most recent history, CLOV shares have underperformed the stock market with its stock returning -11.6% in the last 3 month period and -16.7% for the last 2 week period, while SPY has returned -10.1% and -5.9%, respectively.
CLOV support price is $3.59 and resistance is $3.95 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CLOV shares will trade within this expected range on the day.